Hence, IDH-mutated NSCLC can be clearly distinguished from IDH wildtype cases by MALDI-MSI, as detected intensities of oncometabolite 2HG were found to be 45 times higher than the average level in tumor regions. This evidence concerns the gene IDH1 and neoplasm.